KO 대한민국

David Jin


David Jin

David Jin is a member of Barings Alternative Investments, a global real estate, private equity and real assets platform. David is a part of the Private Equity/Real Assets team and is responsible for sourcing and underwriting Pharmaceutical investments. David has worked in the industry since 2012. Prior to joining the firm in 2017, David was a Director of Corporate Development for Sorrento Therapeutics, a clinical-stage antibody-focused biopharma company, where he was involved with clinical/portfolio strategy and acquisitions. Prior to that, David was a management consultant at IQVIA, consulting for global pharmaceutical companies on market access, pricing, transaction advisory, and strategy and portfolio analysis. David received a B.S. from Northwestern University, where he graduated from the Mathematical Methods in the Social Sciences program with a double major in Industrial Engineering.


베어링자산운용은 당사 웹사이트 사용자들에게 최적화된 웹 경험을 제공하고자 쿠키를 사용합니다.
베어링 웹사이트를 이용함으로써, 당사의 쿠키정책법적 & 개인정보고지사항에 동의하는 것으로 간주합니다.